BBHC
CMD

Brown Brothers Harriman & Co’s Cantel Medical Corporation CMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-108
Closed -$4K – 1263
2020
Q1 		$4K Buy
+108
New +$6.14K ﹤0.01% 848

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Brothers Harriman & Co's CMD Position: Q2 2020 in Review

Brown Brothers Harriman & Co sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 108 shares — an estimated $4K sold.

Brown Brothers Harriman & Co first reported a position in CMD in Q1 2020 and held it in 1 quarter. The position peaked at $4K in Q1 2020. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Brown Brothers Harriman & Co reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 108 Cantel Medical Corporation shares in Q2 2020, an estimated $4K.
  • Brown Brothers Harriman & Co first reported a position in Cantel Medical Corporation in Q1 2020 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Cantel Medical Corporation position peaked at $4K in Q1 2020.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2020, filed 13 Aug 2020.